DT News - UK - GlaxoSmithKline announces name of independent healthcare company

Brendan Day

Tue. 1 March 2022

save

LONDON, UK: In 2018, GlaxoSmithKline (GSK), one of the world’s largest pharmaceutical companies, outlined its intention to separate its consumer healthcare portfolio into an independent entity. This is set to take place in mid-2022, and GSK has now revealed that the new company will be called Haleon.

The separation of GSK’s healthcare business, which is subject to approval from shareholders, will take place via a demerger of at least 80% of GSK’s stake in the business to shareholders later this year. According to a press release issued by GSK, Haleon’s name is derived from the words “hale”, an old English word meaning “in good health”, and “Leon”, a name associated with strength. Included in Haleon’s portfolio will be the paracetamol brand Panadol, the non-steroidal anti-inflammatory Voltaren and the toothpaste brand Sensodyne.

In January, GSK revealed that it had recently rejected three takeover offers for its consumer healthcare business from multinational conglomerate Unilever, including a bid of £50 billion (approximately US$67 billion). GSK said that Unilever had undervalued the business and forecast annual organic sales growth of 4 to 6%.

“Introducing Haleon to the world marks another step in our journey to become a new, standalone company,” said Haleon CEO designate Brian McNamara. “Our name is grounded in our purpose to deliver better everyday health with humanity and to be a world leader in consumer healthcare. We are on track to launch Haleon in mid-2022 and our business momentum is strong.”

Emma Walmsley, GSK CEO, added that “Haleon has enormous potential to improve health and well-being across the world with strong prospects for growth, and through listing will unlock significant value for GSK shareholders”.

Tags:

To post a reply please login or register

Company director of London dental practice disqualified

LONDON, UK: The UK’s Insolvency Service in London has announced its disqualification of the director of a London-based dental clinic. India-born Dr ...

GDC announces reappointment of Moyes

LONDON, UK: The Privy Council of the General Dental Council (GDC) has approved the appointment of William (Bill) Moyes as chair for another term. He will ...

Bupa announces acquisition of Oasis complete

LONDON, UK: The acquisition of the Oasis Healthcare Group has been completed, the Bupa health care group has said. The news comes after the European ...

Winners of DLA awards announced

NOTTINGHAM, UK: Just introduced to dental markets in the UK last year, enigmalife+ denture teeth from Schottlander recently scooped a Trade Award from the ...

UK healthcare regulators unite in support of reflective practice

LONDON, UK: The chief executives of nine of the UK’s healthcare statutory regulators have released a joint statement stressing the benefits and importance...

Launch of Aligner Dental Academy announced

Aligner Dental Academy is a next-level education and support for dentists striving to deliver gold standard aligner therapy and accredit their work.

Save the date: GC announces One Week of Excellence in Japan in October 2026

TOKYO, Japan: Leading dental manufacturer GC Corp. has invited global dental professionals to save the date for its sixth International Dental Symposium, ...

Software of Excellence and Zesty announce partnership

LONDON, UK: Since 2013, patients in the UK have been able to find dental and other health care providers and book appointments via the Zesty website. A new ...

New report spotlights plight of healthcare workers during COVID-19 pandemic

LONDON, UK: A report from Amnesty International, released last month, has revealed that more than 3,000 healthcare workers worldwide have died as a result ...